Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Measuring unbound versus total piperacillin concentrations in plasma of critically ill patients: methodological issues and relevance.

Colman S, Stove V, De Waele JJ, Verstraete AG.

Ther Drug Monit. 2019 Sep 1. doi: 10.1097/FTD.0000000000000602. [Epub ahead of print]

PMID:
30633089
2.

Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia.

Davies SJ, Burhan AM, Kim D, Gerretsen P, Graff-Guerrero A, Woo VL, Kumar S, Colman S, Pollock BG, Mulsant BH, Rajji TK.

J Psychopharmacol. 2018 May;32(5):509-523. doi: 10.1177/0269881117744996. Epub 2018 Jan 17.

3.

Comparing Two Models of Integrated Behavioral Health Programs in Pediatric Primary Care.

Germán M, Rinke ML, Gurney BA, Gross RS, Bloomfield DE, Haliczer LA, Colman S, Racine AD, Briggs RD.

Child Adolesc Psychiatr Clin N Am. 2017 Oct;26(4):815-828. doi: 10.1016/j.chc.2017.06.009.

PMID:
28916016
4.

Collaborative Care for Psychiatric Disorders in Older Adults: A Systematic Review.

Dham P, Colman S, Saperson K, McAiney C, Lourenco L, Kates N, Rajji TK.

Can J Psychiatry. 2017 Nov;62(11):761-771. doi: 10.1177/0706743717720869. Epub 2017 Jul 18. Review.

5.

Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.

Qian Y, Bhowmik D, Bond C, Wang S, Colman S, Hernandez RK, Cheng P, Intorcia M.

Cancer Med. 2017 Jul;6(7):1523-1530. doi: 10.1002/cam4.1075. Epub 2017 Jun 14.

6.

Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board?

De Cock PA, Desmet S, De Jaeger A, Biarent D, Dhont E, Herck I, Vens D, Colman S, Stove V, Commeyne S, Vande Walle J, De Paepe P.

J Antimicrob Chemother. 2017 Mar 1;72(3):801-804. doi: 10.1093/jac/dkw495.

PMID:
27999035
7.

Safe management of ileostomates with high-output stomas.

Goodey A, Colman S.

Br J Nurs. 2016 Dec 8;25(22):S4-S9. Review.

PMID:
27935344
8.

The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.

Ahmad H, Taylor BV, van der Mei I, Colman S, O'Leary BA, Breslin M, Palmer AJ.

Mult Scler. 2017 Jul;23(8):1157-1166. doi: 10.1177/1352458516672014. Epub 2016 Oct 3. Erratum in: Mult Scler. 2016 Dec;22(14 ):NP13.

PMID:
27698247
9.

A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study.

Anastassopoulos K, Farraye FA, Knight T, Colman S, Cleveland MV, Pelham RW.

Dig Dis Sci. 2016 Oct;61(10):2993-3006. doi: 10.1007/s10620-016-4214-2. Epub 2016 Jun 9.

10.

Assessment Of Renal Function Among Patients With Bone Metastases From Solid Tumors.

Qian Y, Bhowmik D, Bond TC, Wang X, Colman S.

Value Health. 2015 Nov;18(7):A439. doi: 10.1016/j.jval.2015.09.1069. Epub 2015 Oct 20. No abstract available.

11.

SOCIETAL COSTS ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN THE UNITED STATES.

Brown MM, Brown GC, Lieske HB, Tran I, Turpcu A, Colman S.

Retina. 2016 Feb;36(2):285-98. doi: 10.1097/IAE.0000000000000717.

PMID:
26428606
12.

Genetic and functional diversity of propagating cells in glioblastoma.

Piccirillo SG, Colman S, Potter NE, van Delft FW, Lillis S, Carnicer MJ, Kearney L, Watts C, Greaves M.

Stem Cell Reports. 2015 Jan 13;4(1):7-15. doi: 10.1016/j.stemcr.2014.11.003. Epub 2014 Dec 18.

13.

The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support Needs.

Colman S, O'Leary BA, Palmer AJ, Simmons R.

Value Health. 2014 Nov;17(7):A809-10. doi: 10.1016/j.jval.2014.08.543. Epub 2014 Oct 26. No abstract available.

14.

Cross-Country Comparison of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe.

Blais J, Krasa HB, Szende A, Colman S, Schaefer C, Dale P, Robinson P, O'Reilly K.

Value Health. 2014 Nov;17(7):A530. doi: 10.1016/j.jval.2014.08.1679. Epub 2014 Oct 26. No abstract available.

15.

An Evaluation of Medical Resource Utilisation In Patients With Autosomal Dominant Polycystic Kidney Disease In Europe.

Blais J, Krasa HB, Szende A, Colman S, Schaefer C, Dale P, Robinson P, O'Reilly K.

Value Health. 2014 Nov;17(7):A530. doi: 10.1016/j.jval.2014.08.1680. Epub 2014 Oct 26. No abstract available.

16.

Vision-related function after ranibizumab treatment for diabetic macular edema: results from RIDE and RISE.

Bressler NM, Varma R, Suñer IJ, Dolan CM, Ward J, Ehrlich JS, Colman S, Turpcu A; RIDE and RISE Research Groups.

Ophthalmology. 2014 Dec;121(12):2461-72. doi: 10.1016/j.ophtha.2014.07.008. Epub 2014 Aug 20.

PMID:
25148789
17.

Prevalence of and risk factors for diabetic macular edema in the United States.

Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, Selvin E, Dolan C, Fine J, Colman S, Turpcu A.

JAMA Ophthalmol. 2014 Nov;132(11):1334-40. doi: 10.1001/jamaophthalmol.2014.2854.

18.

Estimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatment.

Mitchell P, Bressler N, Doan QV, Dolan C, Ferreira A, Osborne A, Rochtchina E, Danese M, Colman S, Wong TY.

PLoS One. 2014 Jun 30;9(6):e101072. doi: 10.1371/journal.pone.0101072. eCollection 2014.

19.

Programs to reduce teen pregnancy, sexually transmitted infections, and associated sexual risk behaviors: a systematic review.

Goesling B, Colman S, Trenholm C, Terzian M, Moore K.

J Adolesc Health. 2014 May;54(5):499-507. doi: 10.1016/j.jadohealth.2013.12.004. Epub 2014 Feb 11. Review.

PMID:
24525227
20.

Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States.

Bressler NM, Varma R, Doan QV, Gleeson M, Danese M, Bower JK, Selvin E, Dolan C, Fine J, Colman S, Turpcu A.

JAMA Ophthalmol. 2014 Feb;132(2):168-73. doi: 10.1001/jamaophthalmol.2013.6426.

Supplemental Content

Loading ...
Support Center